Ph.D. Students (Alumni)
Husamuddin Ansari, M.D., Ph.D.
Dates: 9/95-7/00
University: Columbia University, New York, NY, USA
Thesis Title: “A novel role for cyclophilin A as a regulator of nuclear transport”
Current Position: Opthalmology Consultants of Boston, Boston, MA, USA
Douglas Craig Braaten, Ph.D.
Dates: 9/96-12/99
University: Columbia University, New York, NY, USA
Thesis Title: “Cyclophilin A is required for wild-type replication kinetics of HIV-1″
Current Position: Executive Director, Science Publications and Editor-in-Chief, New York Academy of Sciences, New York, NY, USA
Mohammed Asmal, M.D., Ph.D.
Dates: 9/97-12/01
University: Columbia University, New York, NY, USA
Thesis Title: “Charact. of Ppia-/- mice and regulation of translation in CD4+ Th2 cells”
Current Position: Senior Medical Director at bluebirdbio.
Clinical lead for gene therapy program in hemoglobinopathies.
Cagan Gurer, Ph.D.
Dates: 9/98-5/04
University: Columbia University, New York, NY, USA
Thesis Title: ” HIV-1 Gag interacting Host Factors”
Current Position: Senior staff Scientist, Regeneron Pharmaceuticals, Tarrytown, NY, USA
David Sayah, M.D., Ph.D.
Dates: 9/01-12/04
University: Columbia University, New York, NY, USA
Thesis Title: “Characterization and cloning of host factors that restrict HIV-1”
Current Position: Assistant Professor, UCLA Medical Center, Los Angeles, CA, USA
Elena Sokolskaja, Ph.D.
Dates: 1/02-11/06
University: Freie Universität, Berlin, Germany
Thesis Title: “Host factors modulating HIV-1 infectivity and restriction”
Current Position: Analytical Development Scientist, The Cell Catapult, London, UK
Sarah Sebastian, Ph.D.
Dates: 9/03-12/06
University: Columbia University, New York, NY, USA
Thesis Title: “Investigating the mechanism of TRIM5-mediated restriction of retroviruses”
Current Position: Postdoctoral Researcher, The Jenner Institute, University of Oxford, Oxford, UK
Martha Neagu, M.D., Ph.D.
Dates: 7/02-11/08
University: Columbia University, New York, NY, USA
Thesis Title: “HIV-1 inhibition by human TRIM5-Cyp fusion proteins”
Current Position: Instructor, Harvard Medical School; Director, Neuro-Oncology Program, VA Boston Healthcare System; Associate Neurologist, Brigham and Women’s Hospital, Boston, MA, USA
Thomas Pertel, Ph.D.
Dates: 9/05-5/09
University: Vita-Salute San Raffaele University, Milano, Italy
Thesis Title: “TRIM5 and innate immunity”
Current Position: Senior Scientist, Pfizer Pharmaceuticals, San Francisco, CA, USA
Frederico Santoni, Ph.D.
Dates: 3/09-7/11
University: University of Geneva, Switzerland
Thesis Title: “In silico analysis of retroviral integration”
Current Position: Senior Researcher, University Hospital of Geneva, Geneva, Switzerland
Hanni Bartels, M.D., Ph.D.
Dates: 3/09-5/12
University: University of Geneva, Switzerland
Thesis Title: “Post-transcriptional regulation of gammaretroviral gag and env”
Current Position: Fellow in Infectious Diseases, University Hospital of Basel, Basel, Switzerland
Alberto Delaco, Ph.D.
Dates: 10/08-10/12
University: University of Geneva, Switzerland
Thesis Title: “HIV-1 capsid plays essential roles in the early steps of viral replication”
Current Position: Postdoctoral Fellow, EPFL, Lausanne, Switzerland
Christian Reinhard, Ph.D.
Dates: 5/09-10/13
University: University of Geneva, Switzerland
Thesis Title: “HIV innate immune detection and evasion”
Current Position: Product Manager, BÜHLMANN Laboratories AG, Basel, Switzerland
Josefina Lascano, Ph.D.
Dates: 5/09-4/14
University: University of Geneva, Switzerland
Thesis Title: “Innate immune signaling and the contribution of different regions of capsid to HIV-1 restriction by TRIM5”
Current Position: Scientist at the Institute of Global Health, University of Geneva, Geneva, Switzerland